Clinical Trials Directory

Trials / Unknown

UnknownNCT00671684

Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease

Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the diagnostic yield with endoscopic mucosal resection (EMR) in hirschsprung's disease versus that of standard rectal suction biopsy. In order to compare EMR versus rectal suction biopsy, patients' diagnostic specimens will be analyzed by tissue size, the presence of submucosal tissue, and positive acteylcholinesterase staining. Additionally, the proportion of patients who would have required subsequent full thickness surgical biopsy with each technique will be compared. Biopsy results will be compared with clinical data including history, Bristol stool scale, anorectal manometry results and SITZ markers studies. Finally, the estimated costs that would have been incurred with each method will be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic Mucosal Resection (EMR)EMR is a common procedure in gastroenterology. The technique involves placing a band around a piece of mucosa in the GI tract. The band and the tissue are then removed using a cautery snare. The technique can be used to obtain tissue for diagnostic purposes or to remove lesions for therapeutic purposes.

Timeline

Start date
2007-10-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2008-05-05
Last updated
2008-05-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00671684. Inclusion in this directory is not an endorsement.